Daily BriefsEvent-Driven

Daily Brief Event-Driven: China ADRs Delisting – Tide Is Turning – Non-HK Listed ADRs Are Already Outperforming and more

In today’s briefing:

  • China ADRs Delisting – Tide Is Turning – Non-HK Listed ADRs Are Already Outperforming
  • MACA: Thiess’ Unsurprising Bump. NRW’s Move, If Any
  • Link Net’s MTO of IDR4,800 from Axiata Open from 30 August
  • SENSEX Index Rebalance Preview: Adani Green Could Replace Dr. Reddy
  • MACA’s Revised Thiess Offer Makes an NRW Rival Offer Increasingly Unlikely
  • ResApp’s Scheme Meeting on 7 September Still Faces Headcount Test Risk
  • Hanjin Kal Club Deal: Shorting on Waning Proxy Fight & Flow Trading on MSCI Inclusion

China ADRs Delisting – Tide Is Turning – Non-HK Listed ADRs Are Already Outperforming

By Sumeet Singh

  • On 26th Aug 2022, PCAOB and CSRC announced that they had entered into an agreement granting US authorities access to investigate public accounting firms headquartered in China and HK.
  • On 2nd Apr 2022, CSRC put out a draft for public comments on the revision of certain provisions which would allow easier access by overseas regulators to China ADRs audits.
  • In this note, we’ll talk about the latest developments and its implications.

MACA: Thiess’ Unsurprising Bump. NRW’s Move, If Any

By David Blennerhassett

  • Back on the 26th July, diversified contractor MACA Ltd (MLD AU) announced a friendly off-market cash offer from fellow contractor Thiess, at A$1.025/share, a 28.1% premium to the undisturbed price.
  • The Bidder’s Statement was dispatched on the 9 August. After rejecting NRW Holdings (NWH AU)‘s non-binding proposal (implied consideration of $1.085/share), MACA dispatched the Target Statement on the 25 August.
  • Thiess has now lifted its all-cash Offer to A$1.075/share – a 34.4% to undisturbed. MACA is trading marginally through the revised terms. The first closing date is the 12 September. 

Link Net’s MTO of IDR4,800 from Axiata Open from 30 August

By Arun George

  • On 22 June, Axiata Group (AXIATA MK) and XL Axiata (EXCL IJ) completed the acquisition of a combined 63.45% interest in Link Net (LINK IJ) for approximately RM2.63 billion (IDR8.72 trillion).
  • Today, Axiata announced that the mandatory tender offer (MTO) runs from 30 August to 28 September. The MTO price is IDR4,800 with no minimum acceptance condition.
  • At the current price of IDR4,740 per share, the gross and annualised spread for a mid-October payment is 1.3% and 9.1%, respectively.

SENSEX Index Rebalance Preview: Adani Green Could Replace Dr. Reddy

By Brian Freitas


MACA’s Revised Thiess Offer Makes an NRW Rival Offer Increasingly Unlikely

By Arun George

  • Theiss has improved its MACA Ltd (MLD AU) offer from A$1.025 to A$1.075 per share. The offer is conditional on 90% minimum acceptances, FIRB approval and no prescribed occurrences.
  • Theiss increased its shareholding to 15.90% of outstanding shares due to acceptances from MACA founders and directors. This is a stumbling block to a potential NRW Holdings (NWH AU) scheme. 
  • While the value of NRW’s default option remains higher than Thiess’ revised offer, it is increasingly unlikely that NRW will start a bidding war. 

ResApp’s Scheme Meeting on 7 September Still Faces Headcount Test Risk

By Arun George

  • Resapp Health (RAP AU)’s scheme meeting date has been set for 7 September. Pfizer Inc (PFE US)’s A$0.208 per share is its best and final offer.
  • The Board hoped that the threat of a discounted equity raise and Pfizer’s final offer would sway the retail shareholders’ NO vote camp. However, there remains a vocal NO camp.
  • The headcount test remains a key risk. The upside (9.5% spread to the offer) vs downside (likely equity raise at a huge discount) is an unfavourable risk/reward profile.

Hanjin Kal Club Deal: Shorting on Waning Proxy Fight & Flow Trading on MSCI Inclusion

By Sanghyun Park

  • Bando sold all of its 17% stakes through a club deal. Of this, about 3.8% went to LX Pantos. The remaining 13% found a new home among several institutional investors.
  • Outright shorting for Hanjin Kal seems to require a bit more cautious approach. That’s because there is still no definitive information on the owners of the 13% stake.
  • If the price correction does not go as harshly as expected and expectations for a proxy battle resurface, we should consider switching to flow trading aimed at MSCI inclusion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars